Sign In

Brad Fackler Joins Maryland Commerce to Lead BioHealth and Life Sciences Team

​Led sales and marketing teams at Novartis, Sucampo Pharmaceuticals
 
BALTIMORE, MD (May 5, 2016) – Brad Fackler, an experienced leader and innovator in the life sciences industry, has joined the Maryland Department of Commerce as the senior director of biohealth and life sciences. In his new role, Mr. Fackler will work to attract new life sciences companies to Maryland, as well as reach out to the state’s more than 500 current life sciences companies to help them grow and create new jobs. F​​ackler will also work closely with the Maryland Life Sciences Advisory Board (LSAB) to continue positioning Maryland as a top global biotech destination.

“We are fortunate to have attracted someone with the depth and breadth of knowledge of Brad Fackler to further strengthen this vital sector of our economy," said Maryland Commerce Secretary Mike Gill. “Having worked in many areas of this industry, including leadership positions in sales and marketing at major companies, gives Brad a unique perspective in attracting new companies to the state, as well as helping our innovative sciences companies in Maryland grow and thrive.”
 
“I look forward to working closely with Life Sciences Advisory Board and Maryland’s dedicated life sciences community to build on the great work that has been done to advance Maryland’s position in the global life sciences community," said Mr. Fackler. “Working for an industry leader like Novartis, as well as most recently heading up a start-up company, helps me to understand the tremendous opportunities and potential of Maryland’s life sciences companies and what we need to do to continue to grow the industry.”
 
Prior to joining Commerce, Mr. Fackler previously served as the CEO of Cellona Therapeutics, a start-up technology transfer company in Bethesda that focused on the oncology sector. While at Cellona, Mr. Fackler successfully raised nearly $400,000 to support the development of a metastatic melanoma treatment. He also was the co-founder and principal of Kinect Point in Bethesda, which provides strategic consulting services to the biotechnology and biopharmaceutical industries and helps companies improve business performance to maximize the value of the scientific technology. From 2005 to 2009, Mr. Fackler was the executive vice president of commercial operations for Sucampo Pharmaceuticals, a biopharmaceutical company in Bethesda, and led the domestic and global sales and marketing functions. Mr. Fackler spent more than 25 years with Novartis in East Hanover, N.J, where he held a number of leadership positions, including executive director of the hospital division where he led a sales team focusing on academic medical centers in the U.S.  He has a bachelor’s of science from Otterbein University and an M.B.A. from New York University, Leonard Stern School of Business. He resides in Montgomery County. 

Home to more than 500 life sciences companies and 50 research-intense federal institutes and outstanding academic centers including NIH, the University of Maryland and Johns Hopkins, Maryland is well positioned in the global life sciences industry and has been recognized as one of the top tier states highly specialized in overall bioscience development. Since the early 1990s, Maryland has focused on bioscience development and was one of the first states to develop a strategic plan for the industry.
 
About Maryland Commerce
The Maryland Department of Commerce stimulates private investment and creates jobs by attracting new businesses, encouraging the expansion and retention of existing companies, and providing financial assistance to Maryland companies. The Department promotes the State's many economic advantages and markets local products and services at home and abroad to spur economic development and international investment, trade and tourism. Because they are major economic generators, the Department also supports the Arts, film production, sports and other special events. For more information, visit commerce.maryland.gov.
Close window
Close Disclaimer

Google Translate Disclaimer

The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology ​​​to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.